- Home
- UNCY vs CMU Comparison
UNCY vs CMU Comparison
Compare UNCY & CMU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UNCY
- CMU
- Stock Information
- Founded
- UNCY 2016
- CMU 1987
- Country
- UNCY United States
- CMU United States
- Employees
- UNCY N/A
- CMU N/A
- Industry
- UNCY Biotechnology: Pharmaceutical Preparations
- CMU Investment Managers
- Sector
- UNCY Health Care
- CMU Finance
- Exchange
- UNCY Nasdaq
- CMU Nasdaq
- Market Cap
- UNCY 74.2M
- CMU 88.7M
- IPO Year
- UNCY 2021
- CMU N/A
- Fundamental
- Price
- UNCY $4.63
- CMU $3.47
- Analyst Decision
- UNCY Strong Buy
- CMU
- Analyst Count
- UNCY 5
- CMU 0
- Target Price
- UNCY $55.20
- CMU N/A
- AVG Volume (30 Days)
- UNCY 510.5K
- CMU 82.4K
- Earning Date
- UNCY 11-12-2025
- CMU 01-01-0001
- Dividend Yield
- UNCY N/A
- CMU 4.08%
- EPS Growth
- UNCY N/A
- CMU N/A
- EPS
- UNCY N/A
- CMU 0.07
- Revenue
- UNCY N/A
- CMU N/A
- Revenue This Year
- UNCY N/A
- CMU N/A
- Revenue Next Year
- UNCY $4,481.14
- CMU N/A
- P/E Ratio
- UNCY N/A
- CMU $47.57
- Revenue Growth
- UNCY N/A
- CMU N/A
- 52 Week Low
- UNCY $3.40
- CMU $2.78
- 52 Week High
- UNCY $11.00
- CMU $3.38
- Technical
- Relative Strength Index (RSI)
- UNCY 61.71
- CMU 60.59
- Support Level
- UNCY $3.72
- CMU $3.42
- Resistance Level
- UNCY $4.80
- CMU $3.48
- Average True Range (ATR)
- UNCY 0.24
- CMU 0.03
- MACD
- UNCY 0.07
- CMU -0.00
- Stochastic Oscillator
- UNCY 75.00
- CMU 71.43
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.
About CMU MFS Municipal Income Trust
Mfs High Yield Municipal Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to seek high current income exempt from federal income tax. The fund invests a majority of its net assets, including assets attributable to preferred shares and borrowings for investment purposes, in tax-exempt bonds and tax-exempt notes. The company invest various top Healthcare companies, Airport, Universities (Secondary Schools), Universities (Dormitories), and many more, out of maximum revenue is gained from Healthcare Hospitals and Long Term Care.